Figure 2

Baseline characteristics of treatment and endpoints. Leaves indicate endpoints for the respective patient subgroup. Endpoints refer to the respective patient subgroup, denoted by their parent node, and are not mutually exclusive. For patients treated with BMS, clinical restenosis occurred mostly during the first 12 months after intervention, whereas it occurred mostly after 12 months for patients treated with DES.